Safety Profiles of mRNA COVID-19 Vaccines Using World Health Organization Global Scale Database (VigiBase): A Latent Class Analysis

被引:0
|
作者
Min-Taek Lee
Wonbin Choi
Seung-Hun You
Sewon Park
Jeong-Yeon Kim
Dal Ri Nam
Ju Won Lee
Sun-Young Jung
机构
[1] Chung-Ang University,College of Pharmacy
[2] The Graduate School of Chung-Ang University,Department of Global Innovative Drugs
来源
关键词
COVID-19; mRNA vaccine; Serious adverse event; VigiBase; Latent class analysis; Cluster;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:443 / 458
页数:15
相关论文
共 50 条
  • [21] Association of Cerebral Venous Thrombosis with mRNA COVID--19Vaccines:A Disproportionality Analysis of theWorld Health Organization Pharmacovigilance Database
    Song, Tae-Jin
    CEREBROVASCULAR DISEASES, 2023, 52 : 150 - 150
  • [22] Safety of mRNA-Platform based Covid-19 Vaccines in Pediatric Population: An Analysis of the European Pharmacovigilance Database Eudravigilance
    Ruggiero, R.
    Pentella, C.
    Mascolo, A.
    Gaio, M.
    Mauro, G. D.
    Scavone, C.
    Sportiello, L.
    Rossi, F.
    Capuano, A.
    DRUG SAFETY, 2022, 45 (10) : 1210 - 1210
  • [23] Safety of mRNA-platform based COVID-19 vaccines in pediatric population: an Analysis of the European pharmacovigilance database Eudravigilance
    Ruggiero, R.
    Stelitano, B.
    Mascolo, A.
    Gaio, M.
    Balzano, N.
    Sportiello, L.
    Capuano, A.
    Rossi, F.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S61 - S62
  • [24] Drug interactions with apixaban: A systematic review of the literature and an analysis of VigiBase, the World Health Organization database of spontaneous safety reports
    Fernandez, Silvia
    Lenoir, Camille
    Samer, Caroline
    Rollason, Victoria
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2020, 8 (05):
  • [25] The World Health Organization COVID-19 surveillance database (vol 21, 167, 2022)
    Allan, Maya
    Lievre, Maja
    Laurenson-Schafer, Henry
    de Barros, Stephane
    Jinnai, Yuka
    Andrews, Sophie
    Stricker, Thomas
    Formigo, Jesus Perez
    Schultz, Craig
    Perrocheau, Anne
    Fitzner, Julia
    INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH, 2023, 22 (01)
  • [26] A Disproportionality Analysis for Association of Systemic Capillary Leak Syndrome with COVID-19 Vaccination Using the World Health Organization Pharmacovigilance Database
    Park, Jin
    Kim, Dongyeop
    Song, Tae-Jin
    VACCINES, 2022, 10 (06)
  • [27] Safety Profile of Antiviral Therapies for the Early Treatment/Prevention of COVID-19: Analysis of the International Pharmacovigilance Database VigiBase
    Bellitto, C.
    Ciccimarra, F.
    Arzenton, E.
    Luxi, N.
    Cutroneo, P. M.
    Poluzzi, E.
    Raschi, E.
    Moretti, U.
    Trifiro, G.
    DRUG SAFETY, 2022, 45 (10) : 1235 - 1235
  • [28] Higher rates of COVID-19 but less severe infections reported for patients on Dupilumab: a Big Data analysis of the World Health Organization VigiBase
    Mahroum, N.
    Damiani, G.
    Watad, A.
    Amital, H.
    Bragazzi, N. L.
    Farah, R.
    Wu, J.
    Kong, J. D.
    Bridgewood, C.
    McGonagle, D.
    Khamisy-Farah, R.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (18) : 5865 - 5870
  • [29] Emergency use of COVID-19 vaccines recommended by the World Health Organization (WHO) as of June 2021
    Cui, Xiaoni
    Wang, Pengxiang
    Wei, Zhun
    DRUG DISCOVERIES AND THERAPEUTICS, 2021, 15 (04): : 222 - 224
  • [30] Latent Class Analysis of COVID-19 Experiences, Social Distancing, and Mental Health
    Frounfelker, Rochelle L.
    Li, Zhi Yin
    Santavicca, Tara
    Miconi, Diana
    Rousseau, Cecile
    AMERICAN JOURNAL OF ORTHOPSYCHIATRY, 2022, 92 (01) : 121 - 132